tirzepatide dopamine reduces food intake and appetite, and affects brain functioning, more than placebo and liraglutide Dual GLP‑1 and GIP Agonist

Everwell Pharmacy

Read more: #FDAApproval #NovaNordisk #CVRisk #PharmaInnovation #PharmaIndustrialindia To view or add a comment, sign in At Cipla, we remain steadfast in our commitment to advancing patient care by facilitating access to the best of global scientific innovation

The GIP component enhances insulin secretion in a glucose-dependent manner and may contribute additional metabolic benefits

GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) deliver remarkable weight loss but create a critical nutritional challenge: maintaining adequate protein intake

While this helps in controlling blood sugar levels by slowing the release of glucose into the bloodstream, it also means that food lingers longer in your digestive system